These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 35460236)
1. Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8+ T cells in giant cell arteritis. Reitsema RD; van der Geest KSM; Sandovici M; Jiemy WF; Graver JC; Abdulahad WH; Boots AMH; Heeringa P; Brouwer E Rheumatology (Oxford); 2022 Dec; 62(1):417-427. PubMed ID: 35460236 [TBL] [Abstract][Full Text] [Related]
2. Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients. van Nieuwland M; Esen I; Reitsema RD; Abdulahad WH; van Sleen Y; Jiemy WF; Sandovici M; Brouwer E; van Bon L Front Immunol; 2023; 14():1197293. PubMed ID: 37398666 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal expression profiling of CD4+ and CD8+ cells in patients with active to quiescent giant cell arteritis. De Smit E; Lukowski SW; Anderson L; Senabouth A; Dauyey K; Song S; Wyse B; Wheeler L; Chen CY; Cao K; Wong Ten Yuen A; Shuey N; Clarke L; Lopez Sanchez I; Hung SSC; Pébay A; Mackey DA; Brown MA; Hewitt AW; Powell JE BMC Med Genomics; 2018 Jul; 11(1):61. PubMed ID: 30037347 [TBL] [Abstract][Full Text] [Related]
5. Involvement and prognosis value of CD8(+) T cells in giant cell arteritis. Samson M; Ly KH; Tournier B; Janikashvili N; Trad M; Ciudad M; Gautheron A; Devilliers H; Quipourt V; Maurier F; Meaux-Ruault N; Magy-Bertrand N; Manckoundia P; Ornetti P; Maillefert JF; Besancenot JF; Ferrand C; Mesturoux L; Labrousse F; Fauchais AL; Saas P; Martin L; Audia S; Bonnotte B J Autoimmun; 2016 Aug; 72():73-83. PubMed ID: 27236507 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory Cell Composition and Immune-Related microRNA Signature of Temporal Artery Biopsies From Patients With Giant Cell Arteritis. Bolha L; Hočevar A; Suljič A; Jurčić V Front Immunol; 2021; 12():791099. PubMed ID: 35003111 [TBL] [Abstract][Full Text] [Related]
7. CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors? Reitsema RD; Boots AMH; van der Geest KSM; Sandovici M; Heeringa P; Brouwer E Front Immunol; 2021; 12():654109. PubMed ID: 33815414 [TBL] [Abstract][Full Text] [Related]
8. Interferon signature in giant cell arteritis aortitis. Vieira M; Régnier P; Maciejewski-Duval A; Le Joncour A; Darasse-Jèze G; Rosenzwajg M; Klatzmann D; Cacoub P; Saadoun D J Autoimmun; 2022 Feb; 127():102796. PubMed ID: 35123212 [TBL] [Abstract][Full Text] [Related]
9. Giant cell vasculitis is a T cell-dependent disease. Brack A; Geisler A; Martinez-Taboada VM; Younge BR; Goronzy JJ; Weyand CM Mol Med; 1997 Aug; 3(8):530-43. PubMed ID: 9307981 [TBL] [Abstract][Full Text] [Related]
10. Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis. Matsumoto K; Suzuki K; Yoshimoto K; Seki N; Tsujimoto H; Chiba K; Takeuchi T Arthritis Res Ther; 2019 Dec; 21(1):304. PubMed ID: 31888748 [TBL] [Abstract][Full Text] [Related]
11. CTLA-4 Pathway Is Instrumental in Giant Cell Arteritis. Régnier P; Le Joncour A; Maciejewski-Duval A; Darrasse-Jèze G; Dolladille C; Meijers WC; Bastarache L; Fouret P; Bruneval P; Arbaretaz F; Sayetta C; Márquez A; Rosenzwajg M; Klatzmann D; Cacoub P; Moslehi JJ; Salem JE; Saadoun D Circ Res; 2023 Aug; 133(4):298-312. PubMed ID: 37435729 [TBL] [Abstract][Full Text] [Related]
12. CD8+ T lymphocyte subset in giant cell arteritis and related disorders. Elling P; Olsson A; Elling H J Rheumatol; 1990 Feb; 17(2):225-7. PubMed ID: 2138673 [TBL] [Abstract][Full Text] [Related]
13. Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4 Carmona EG; Callejas-Rubio JL; Raya E; Ríos-Fernández R; Villanueva-Martín G; Cid MC; Hernández-Rodríguez J; Ballestar E; Timmermann B; Ortego-Centeno N; Martín J; Márquez A J Autoimmun; 2024 Jan; 142():103124. PubMed ID: 37952293 [TBL] [Abstract][Full Text] [Related]
14. Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis. Lopez-Hoyos M; Bartolome-Pacheco MJ; Blanco R; Rodriguez-Valverde V; Martinez-Taboada VM Ann Rheum Dis; 2004 Jan; 63(1):54-60. PubMed ID: 14672892 [TBL] [Abstract][Full Text] [Related]
15. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review. Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026 [TBL] [Abstract][Full Text] [Related]
16. Temporal small arterial inflammation is common in patients with giant cell arteritis. Zhao CL; Hui Y; Amin A Hum Pathol; 2018 Nov; 81():65-70. PubMed ID: 29953896 [TBL] [Abstract][Full Text] [Related]
17. Mucosal-associated invariant T cells in Giant Cell Arteritis. Ghesquière T; Ciudad M; Ramon A; Greigert H; Gerard C; Cladière C; Thébault M; Genet C; Devilliers H; Maurier F; Ornetti P; Quipourt V; Gabrielle PH; Creuzot-Garcher C; Tarris G; Martin L; Soudry-Faure A; Saas P; Audia S; Bonnotte B; Samson M J Autoimmun; 2021 Jul; 121():102652. PubMed ID: 34000675 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis. Coit P; De Lott LB; Nan B; Elner VM; Sawalha AH Ann Rheum Dis; 2016 Jun; 75(6):1196-202. PubMed ID: 26038090 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of interleukin-22 in patients with giant cell arteritis. Zerbini A; Muratore F; Boiardi L; Ciccia F; Bonacini M; Belloni L; Cavazza A; Cimino L; Moramarco A; Alessandro R; Rizzo A; Parmeggiani M; Salvarani C; Croci S Rheumatology (Oxford); 2018 Jan; 57(1):64-72. PubMed ID: 28968695 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptors in giant cell arteritis. An immunocytochemical, western blot and RT-PCR study. Petursdottir V; Nordborg E; Moraghebi N; Persson M; Nordborg C Clin Exp Rheumatol; 1999; 17(6):671-7. PubMed ID: 10609065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]